Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel Group, Dose-Response Study of SDP-4 Ophthalmic Solution in Subjects With Dry Eye Disease (DED)

NCT03889886 is registered in ClinicalTrials.gov with Silk Technologies, Ltd. as lead sponsor.

NCT NCT03889886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03889886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Multicenter, Double-Masked, Randomized, Vehicle-Controlled, Parallel Group, Dose-Response Study of SDP-4 Ophthalmic Solution in Subjects With Dry Eye Disease (DED)
Lead sponsor
Silk Technologies, Ltd.
Phase
Phase 2
Overall status
Completed
Start date
April 16, 2019
Completion date
October 11, 2019
Enrollment
305 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye